4//SEC Filing
Baity Glenn 4
Accession 0001415889-18-000014
CIK 0001070494other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:24 PM ET
Size
9.3 KB
Accession
0001415889-18-000014
Insider Transaction Report
Form 4
Baity Glenn
VP, GC & Sec.
Transactions
- Sale
Common Stock
2018-01-02$30.14/sh−74,321$2,240,139→ 70,113 total - Exercise/Conversion
Stock Option (right to buy)
2018-01-02−74,321→ 0 totalExercise: $2.18Exp: 2022-03-22→ Common Stock (74,321 underlying) - Exercise/Conversion
Common Stock
2018-01-02$2.18/sh+74,321$162,020→ 144,434 total
Footnotes (4)
- [F1]Includes 457 shares acquired on November 15, 2017 by Mr. Baity under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017 and amended in November 2017.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.335 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F4]25% of the shares subject to the Stock Option vested and became exercisable on March 23, 2013. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001487100
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:24 PM ET
- Size
- 9.3 KB